Some recent research examined Fanconi anemia patients and found that people holding the ALDH2 dominant-negative variant (ALDH2*2) had the tendency of accelerated progression of bone marrow failure (BMF)48,49. Here, ALDH2 is linked to Bone marrow hypocellularity.